Are We There Yet? Assessing Treatment Response in Inflammatory Disease
About this episode
How do prescribers and patients determine whether or not a treatment for psoriasis or eczema provides meaningful response? And what is the right way to make a therapeutic switch? Wendy Cantrell, DNP, CRNP; Joe Gorelick, MSN, FNP-C; David E. Cohen, MD, MPH; and Kara Gooding, MMS, PA-C discuss. Plus, Steve Hawkes, MMS, PA-C shares tips on isotretinoin and Suneel Chilukuri, MD, talks exosomes science.
Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.
Get every episode summarized
Each time The Dermalorian Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Dermalorian Podcast
Still a Big Need: The Dermatology NP/PA Market in 2026
The Dermalorian Podcast
Start from Scratch: Approaches to Itch
The Dermalorian Podcast
MOA FYI: Where Do Emerging AD and PsO Treatments Fit?
The Dermalorian Podcast
Tea Time: Can't-miss Dermatology Developments in 2025
The Dermalorian Podcast